The national standard for heart attack treatment is 90 minutes. Melvin said his team meets that benchmark nearly every time. Most patients remain awake throughout the procedure. “We like to be able to ...

Background Severe aortic stenosis (AS) is commonly associated with advanced cardiac damage, including right ventricular dysfunction (RVD), pulmonary hypertension (PH) and tricuspid regurgitation (TR), ...

Through heavy investment in cardiology care in Thurston County, Pulse Heart Institute is working to increase access to care, ...

John Lock was born with his heart on the opposite side of his chest. It was never an issue until he developed atrial fibrillation — a common heart condition that put his life at risk and created a ...

CMS’ addition of more than 560 codes to the ASC covered procedure list for 2026 has sparked new engagement from ASC leaders interested in expanding service lines, especially for cardiovascular and ...

Explore key takeaways from the inaugural EAPCI Summit highlighting how interventional cardiology is evolving beyond technical ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Cornerstone AI, a leader in intelligent healthcare data cleaning and standardization, today announced the expansion of its strategic partnership with Loopback Health. Following the successful ...

In 2026, the heart of a cardiology practice is no longer just the catheterization lab or the ultrasound suite. It is the data ...

Reimbursement for outpatient cardiology procedures has been a key issue for advocacy groups such as the Ambulatory Surgery Center Association and the American College of Cardiology for years as ...

Claytor Noone Plastic Surgery has expanded its treatment offerings with the addition of FDA-cleared Sofwave, providing ...

Year Ended December 31, 2025NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today ...